Abstract:G protein-coupled receptors (GPCRs) mediate different cell transmembrane signal transduction, and are important drug targets. The beta-arrestin mediated pathway is one of the important ways for GPCRs to play their function, which owns important significance for regulation of the function of GPCRs. However, until now it is still not clear how beta-arrestin interacts with GPCRs and mediates their trans-membraned signal transduction pathway. To address this issue,the CC chemokine receptor 3 (CCR3) was selected to study the interaction between beta-arrestin and GPCRs. Firstly, a co-expression system of beta-arrestin and CCR3 was constructed, and the interaction between beta-arrestin and CCR3 in living cells was analyzed using laser confocal fluorescence microscopy and fluorescence resonance energy transfer techniques. And the regulation effect of beta-arrestin on the chemotaxis of CCR3 stably transfected cells was also studied by RNAi and chemotaxis experiments. In addition, the interaction between beta-arrestin mutant (R169E) and CCR3 was further confirmed using QCM technology in vitro, and their binding constant was also determined. As a result, upon the stimulation of CCL11 (chemokine C-C motif ligand 11), the intracellular distance between beta-arrestin and CCR3 was significantly changed, and beta-arrestin protein was recruited to the cell membrane, which suggests that beta-arrestin could interact with CCR3 and involve in the CCR3-mediated signal transduction process. After silencing beta-arrestin by transfection with beta-arrestin-siRNA, the migration of CCR3 stablely transfected cells induced by CCL11 and CCL24 was significantly decreased, while the migration rate induced by CCL5 was not obviously changed. These results indicated that different chemokines shows different regulatory effects on the interaction between CCR3 and beta-arrestin. In vitro binding experiments further confirmed the interaction between beta-arrestin and CCR3, and the binding constant K-D between beta-arrestin mutant and CCR3 was determined as 1.35 x 10(-7). In conclusion, beta-arrestin can interact with CCR3 in living cells, and plays an important role in CCR3-mediated cell transmembrane signal transduction.

Study On Interaction Of Human Chemokine Receptor Ccr3 And Beta-Arrestin

Beta-Arrestin Differentially Regulates The Chemokine Receptor Cxcr4-Mediated Signaling And Receptor Internalization, And This Implicates Multiple Interaction Sites Between Beta-Arrestin And Cxcr4

Β-Arrestin2 is Critically Involved in CXCR4-mediated Chemotaxis, and This is Mediated by Its Enhancement of P38 MAPK Activation

Study on The Interaction Between Chemokine CCL11-glycosaminoglycan- chemokine Receptor CCR3

Chemokine Receptor Ccr5 Functionally Couples to Inhibitory G Proteins and Undergoes Desensitization

Studying allosteric regulation of chemokines and antagonists using a nanoscale hCCR3 receptor sensor

β-Arrestin1 and β-Arrestin2 Are Required to Support the Activity of the CXCL12/HMGB1 Heterocomplex on CXCR4

Regulation of the Oligomeric Status of CCR3 with Binding Ligands Revealed by Single-Molecule Fluorescence Imaging.

Milligram Production and Biological Activity Characterization of the Human Chemokine Receptor CCR3

Computational Studies of the Binding Modes of Ccr1 Antagonists

Molecular Insights into Ligand Recognition and Activation of Chemokine Receptors CCR2 and CCR3

A high-resolution analysis of arrestin2 interactions responsible for CCR5 endocytosis

Identification of critical residues at the C-terminal tip of ACKR4 regulating chemokine internalization and βarrestin involvement

Inverse Regulation of C-C Chemokine Receptor 3 Oligomerization by Downstream Proteins Indicates Biased Signal Transduction Pathways.

Biophysical characterization of the CXC chemokine receptor 2 ligands

Conformational dynamics underlying atypical chemokine receptor 3 activation

Arrestin-biased AT1R Agonism Induces Acute Catecholamine Secretion Through TRPC3 Coupling

Chemokine receptor hetero-oligomers regulate monocyte chemotaxis

Structural insights into the activation and inhibition of CXC chemokine receptor 3

Distinct Activation Mechanisms of CXCR4 and ACKR3 Revealed by Single-Molecule Analysis of their Conformational Landscapes

A non-GPCR-binding partner interacts with a novel surface on β-arrestin1 to mediate GPCR signaling